Prof Heinz Zwierina (Innsbruck Medical University, Innsbruck, Austria), chair of ITOC 2014, talks to ecancertv about the meeting's key points and future.
Immunotherapy for cancer has taken huge leaps forwards in the last couple of years, and progress is only accelerating, so ITOC is set to...
Published 04/04/14
Prof Inge Marie Svane (Herlev Hospital, Copenhagen University, Copenhagen, Denmark) talks to ecancertv at the 1st Immunotherapy of Cancer Conference ( ITOC ) in Munich about adoptive T-cell therapy (ACT) with tumour infiltrating lymphocytes (TILs).
This is a personalised treatment for cancer...
Published 04/03/14